- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of COVID-19 Medicine will have significant change from previous year. By the most conservative estimates of global COVID-19 Medicine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the COVID-19 Medicine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Medicine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the COVID-19 Medicine, covering the supply chain analysis, impact assessment to the COVID-19 Medicine market size growth rate in several scenarios, and the measures to be undertaken by COVID-19 Medicine companies in response to the COVID-19 epidemic.
Segmentation by product type:
Tablet
Injection
Segmentation by Application:
Patients With Mild Symptoms
Critically Ill
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/players in the market. The key players covered in this report:
Advanz Pharma
Sichuan Sunny Hope
Kyung Poong
Novartis
Sanofi
Mylan
Guangzhou Baiyunshan Guanghua Pharmaceutical
Apotex
Ipca Laboratories
Bayer
Bristol Laboratories
Shanghai Pharma
Shanghai Zhongxisanwei
Zydus Cadila
Rising Pharmaceutical
Sun Pharma
KPC Group
Teva
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global COVID-19 Medicine market size by key regions/countries, type and application.
To understand the structure of COVID-19 Medicine market by identifying its various subsegments.
Focuses on the key global COVID-19 Medicine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the COVID-19 Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of COVID-19 Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the COVID-19 Medicine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global COVID-19 Medicine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global COVID-19 Medicine Market Size 2021-2025
2.1.2 COVID-19 Medicine Market Size CAGR by Region
2.2 COVID-19 Medicine Segment by Type
2.2.1 Tablet
2.2.2 Injection
2.3 COVID-19 Medicine Market Size by Type
2.3.1 Global COVID-19 Medicine Market Size Market Share by Type (2021-2025)
2.3.2 Global COVID-19 Medicine Market Size Growth Rate by Type (2021-2025)
2.4 COVID-19 Medicine Segment by Application
2.4.1 Patients With Mild Symptoms
2.4.2 Critically Ill
2.4.3 Other
2.5 COVID-19 Medicine Market Size by Application
2.5.1 Global COVID-19 Medicine Market Size Market Share by Application (2021-2025)
2.5.2 Global COVID-19 Medicine Market Size Growth Rate by Application (2021-2025)
3 COVID-19 Medicine Key Players
3.1 Date of Key Players Enter into COVID-19 Medicine
3.2 Key Players COVID-19 Medicine Product Offered
3.3 Key Players COVID-19 Medicine Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 Medicine Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 COVID-19 Medicine by Regions
4.1 COVID-19 Medicine Market Size by Regions (2015-2020)
4.2 Americas COVID-19 Medicine Market Size Growth (2015-2020)
4.3 APAC COVID-19 Medicine Market Size Growth (2015-2020)
4.4 Europe COVID-19 Medicine Market Size Growth (2015-2020)
5 Americas
5.1 Americas COVID-19 Medicine Market Size by Countries (2021-2025)
5.2 Americas COVID-19 Medicine Market Size by Type (2021-2025)
5.3 Americas COVID-19 Medicine Market Size by Application (2021-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC COVID-19 Medicine Market Size by Regions
6.2 APAC COVID-19 Medicine Market Size by Type (2021-2025)
6.3 APAC COVID-19 Medicine Market Size by Application (2021-2025)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe COVID-19 Medicine by Countries (2021-2025)
7.2 Europe COVID-19 Medicine Market Size by Type (2021-2025)
7.3 Europe COVID-19 Medicine Market Size by Application (2021-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles
9 Key Investors in COVID-19 Medicine
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……
10 Key Players Analysis
10.1 Advanz Pharma
10.1.1 Advanz Pharma Company Information
10.1.2 COVID-19 Medicine Product Offered
10.1.3 Advanz Pharma COVID-19 Medicine Market Size (2020 VS 2025)
10.1.4 Main Business Overview
10.1.5 Advanz Pharma Latest Developments
10.2 Sichuan Sunny Hope
10.2.1 Sichuan Sunny Hope Company Information
10.2.2 COVID-19 Medicine Product Offered
10.2.3 Sichuan Sunny Hope COVID-19 Medicine Market Size (2020 VS 2025)
10.2.4 Main Business Overview
10.2.5 Sichuan Sunny Hope Latest Developments
10.3 Kyung Poong
10.3.1 Kyung Poong Company Information
10.3.2 COVID-19 Medicine Product Offered
10.3.3 Kyung Poong COVID-19 Medicine Market Size (2020 VS 2025)
10.3.4 Main Business Overview
10.3.5 Kyung Poong Latest Developments
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 COVID-19 Medicine Product Offered
10.4.3 Novartis COVID-19 Medicine Market Size (2020 VS 2025)
10.4.4 Main Business Overview
10.4.5 Novartis Latest Developments
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 COVID-19 Medicine Product Offered
10.5.3 Sanofi COVID-19 Medicine Market Size (2020 VS 2025)
10.5.4 Main Business Overview
10.5.5 Sanofi Latest Developments
10.6 Mylan
10.6.1 Mylan Company Information
10.6.2 COVID-19 Medicine Product Offered
10.6.3 Mylan COVID-19 Medicine Market Size (2020 VS 2025)
10.6.4 Main Business Overview
10.6.5 Mylan Latest Developments
10.7 Guangzhou Baiyunshan Guanghua Pharmaceutical
10.7.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
10.7.2 COVID-19 Medicine Product Offered
10.7.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Market Size (2020 VS 2025)
10.7.4 Main Business Overview
10.7.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Latest Developments
10.8 Apotex
10.8.1 Apotex Company Information
10.8.2 COVID-19 Medicine Product Offered
10.8.3 Apotex COVID-19 Medicine Market Size (2020 VS 2025)
10.8.4 Main Business Overview
10.8.5 Apotex Latest Developments
10.9 Ipca Laboratories
10.9.1 Ipca Laboratories Company Information
10.9.2 COVID-19 Medicine Product Offered
10.9.3 Ipca Laboratories COVID-19 Medicine Market Size (2020 VS 2025)
10.9.4 Main Business Overview
10.9.5 Ipca Laboratories Latest Developments
10.10 Bayer
10.10.1 Bayer Company Information
10.10.2 COVID-19 Medicine Product Offered
10.10.3 Bayer COVID-19 Medicine Market Size (2020 VS 2025)
10.10.4 Main Business Overview
10.10.5 Bayer Latest Developments
10.11 Bristol Laboratories
10.12 Shanghai Pharma
10.13 Shanghai Zhongxisanwei
10.14 Zydus Cadila
10.15 Rising Pharmaceutical
10.16 Sun Pharma
10.17 KPC Group
10.18 Teva
11 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global COVID-19 Medicine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by COVID-19 Medicine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. COVID-19 Medicine Market Size CAGR by Region (2021-2025) ($ Millions)
Table 6. Major Players of Tablet
Table 7. Major Players of Injection
Table 8. Global Market Size by Type (2021-2025) ($ Millions)
Table 9. Global COVID-19 Medicine Market Size Market Share by Type (2021-2025)
Table 10. Global COVID-19 Medicine Market Size by Application (2021-2025) ($ Millions)
Table 11. Global COVID-19 Medicine Market Size Market Share by Application (2021-2025)
Table 12. Date of Global Key Players Enter into COVID-19 Medicine Market
Table 13. Global Key Players COVID-19 Medicine Product Offered
Table 14. Key Players COVID-19 Medicine Funding/Investment ($ Millions)
Table 15. Funding/Investment by Regions
Table 16. Funding/Investment by End Industry
Table 17. Key Players COVID-19 Medicine Valuation & Market Capitalization ($ Millions)
Table 18. Key Players Mergers & Acquisitions, Expansion Plans
Table 19. COVID-19 Medicine New Product/Technology Launches
Table 20. COVID-19 Medicine Industry Partnerships, Agreements, and Collaborations
Table 21. COVID-19 Medicine Industry Mergers and Acquisitions
Table 22. Global COVID-19 Medicine Market Size by Regions 2021-2025 ($ Millions)
Table 23. Global COVID-19 Medicine Market Size Market Share by Regions 2021-2025
Table 24. Americas COVID-19 Medicine Market Size by Countries (2021-2025) ($ Millions)
Table 25. Americas COVID-19 Medicine Market Size Market Share by Countries (2021-2025)
Table 26. Americas COVID-19 Medicine Market Size by Type (2021-2025) ($ Millions)
Table 27. Americas COVID-19 Medicine Market Size Market Share by Type (2021-2025)
Table 28. Americas COVID-19 Medicine Market Size by Application (2021-2025) ($ Millions)
Table 29. Americas COVID-19 Medicine Market Size Market Share by Application (2021-2025)
Table 30. APAC COVID-19 Medicine Market Size by Regions (2021-2025) ($ Millions)
Table 31. APAC COVID-19 Medicine Market Size Market Share by Regions (2021-2025)
Table 32. APAC COVID-19 Medicine Market Size by Type (2021-2025) ($ Millions)
Table 33. APAC COVID-19 Medicine Market Size Market Share by Type (2021-2025)
Table 34. APAC COVID-19 Medicine Market Size by Application (2021-2025) ($ Millions)
Table 35. APAC COVID-19 Medicine Market Size Market Share by Application (2021-2025)
Table 36. Europe COVID-19 Medicine Market Size by Countries (2021-2025) ($ Millions)
Table 37. Europe COVID-19 Medicine Market Size Market Share by Countries (2021-2025)
Table 38. Europe COVID-19 Medicine Market Size by Type (2021-2025) ($ Millions)
Table 39. Europe COVID-19 Medicine Market Size Market Share by Type (2021-2025)
Table 40. Europe COVID-19 Medicine Market Size by Application (2021-2025) ($ Millions)
Table 41. Europe COVID-19 Medicine Market Size Market Share by Application (2021-2025)
Table 42. Key and Potential Regions of COVID-19 Medicine
Table 43. Key Application and Potential Industries of COVID-19 Medicine
Table 44. Key Challenges of COVID-19 Medicine
Table 45. Key Trends of COVID-19 Medicine
Table 46. Company A Company Details
Table 47. Companies Invested by Company A
Table 48. Company A Key Development and Market Layout
Table 49. Company B Company Details
Table 50. Companies Invested by Company B
Table 51. Company B Key Development and Market Layout
Table 52. Company C Company Details
Table 53. Companies Invested by Company C
Table 54. Company C Key Development and Market Layout
Table 55. Company C Company Details
Table 56. Companies Invested by Company C
Table 57. Company C Key Development and Market Layout
Table 58. Advanz Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Advanz Pharma COVID-19 Medicine Market Size (2020 VS 2025)
Table 60. Sichuan Sunny Hope Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Sichuan Sunny Hope COVID-19 Medicine Market Size (2020 VS 2025)
Table 62. Kyung Poong Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Kyung Poong COVID-19 Medicine Market Size (2020 VS 2025)
Table 64. Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Novartis COVID-19 Medicine Market Size (2020 VS 2025)
Table 66. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Sanofi COVID-19 Medicine Market Size (2020 VS 2025)
Table 68. Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Mylan COVID-19 Medicine Market Size (2020 VS 2025)
Table 70. Guangzhou Baiyunshan Guanghua Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Market Size (2020 VS 2025)
Table 72. Apotex Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Apotex COVID-19 Medicine Market Size (2020 VS 2025)
Table 74. Ipca Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Ipca Laboratories COVID-19 Medicine Market Size (2020 VS 2025)
Table 76. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Bayer COVID-19 Medicine Market Size (2020 VS 2025)
Table 78. Bristol Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. Bristol Laboratories COVID-19 Medicine Market Size (2020 VS 2025)
Table 80. Shanghai Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 81. Shanghai Pharma COVID-19 Medicine Market Size (2020 VS 2025)
Table 82. Shanghai Zhongxisanwei Basic Information, Head Office, Major Market Areas and Its Competitors
Table 83. Shanghai Zhongxisanwei COVID-19 Medicine Market Size (2020 VS 2025)
Table 84. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors
Table 85. Zydus Cadila COVID-19 Medicine Market Size (2020 VS 2025)
Table 86. Rising Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 87. Rising Pharmaceutical COVID-19 Medicine Market Size (2020 VS 2025)
Table 88. Sun Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 89. Sun Pharma COVID-19 Medicine Market Size (2020 VS 2025)
Table 90. KPC Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 91. KPC Group COVID-19 Medicine Market Size (2020 VS 2025)
Table 92. Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table 93. Teva COVID-19 Medicine Market Size (2020 VS 2025)
List of Figures
Figure 1. Picture of COVID-19 Medicine
Figure 2. COVID-19 Medicine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global COVID-19 Medicine Market Size Growth Rate 2021-2025 ($ Millions)
Figure 5. COVID-19 Medicine Market Size by Region (2020 & 2025) ($ millions)
Figure 6. Global COVID-19 Medicine Market Size Market Share by Type (2021-2025)
Figure 7. Global Tablet Market Size Growth Rate
Figure 8. Global Injection Market Size Growth Rate
Figure 9. COVID-19 Medicine Consumed in Patients With Mild Symptoms
Figure 10. Global COVID-19 Medicine Market: Patients With Mild Symptoms (2021-2025) ($ Millions)
Figure 11. Global Patients With Mild Symptoms YoY Growth ($ Millions)
Figure 12. COVID-19 Medicine Consumed in Critically Ill
Figure 13. Global COVID-19 Medicine Market: Critically Ill (2021-2025) ($ Millions)
Figure 14. Global Critically Ill YoY Growth ($ Millions)
Figure 15. COVID-19 Medicine Consumed in Other
Figure 16. Global COVID-19 Medicine Market: Other (2021-2025) ($ Millions)
Figure 17. Global Other YoY Growth ($ Millions)
Figure 18. Global COVID-19 Medicine Market Size Market Share by Application (2021-2025)
Figure 19. Global COVID-19 Medicine Market Size in Patients With Mild Symptoms Growth Rate
Figure 20. Global COVID-19 Medicine Market Size in Critically Ill Growth Rate
Figure 21. Global COVID-19 Medicine Market Size in Other Growth Rate
Figure 22. Funding/Investment
Figure 23. Global COVID-19 Medicine Market Size Market Share by Regions 2021-2025
Figure 24. Americas COVID-19 Medicine Market Size 2021-2025 ($ Millions)
Figure 25. APAC COVID-19 Medicine Market Size 2021-2025 ($ Millions)
Figure 26. Europe COVID-19 Medicine Market Size 2021-2025 ($ Millions)
Figure 27. Americas COVID-19 Medicine Market Size Market Share by Countries in 2020
Figure 28. Americas COVID-19 Medicine Market Size Market Share by Type in 2020
Figure 29. Americas COVID-19 Medicine Market Size Market Share by Application in 2020
Figure 30. United States COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 31. Canada COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 32. Mexico COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 33. APAC COVID-19 Medicine Market Size Market Share by Regions in 2020
Figure 34. APAC COVID-19 Medicine Market Size Market Share by Type in 2020
Figure 35. APAC COVID-19 Medicine Market Size Market Share by Application in 2020
Figure 36. China COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 37. Japan COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 38. Korea COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 39. Southeast Asia COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 40. India COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 41. Australia COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 42. Europe COVID-19 Medicine Market Size Market Share by Countries in 2020
Figure 43. Europe COVID-19 Medicine Market Size Market Share by Type in 2020
Figure 44. Europe COVID-19 Medicine Market Size Market Share by Application in 2020
Figure 45. Germany COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 46. France COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 47. UK COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 48. Italy COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Figure 49. Russia COVID-19 Medicine Market Size Growth 2021-2025 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
